Funder: American Cancer Society
Due Dates (Anticipated): December 2026 | June 2027
Funding Amounts: Up to $135,000/year for up to 2 years (max $297,000 total, including 10% indirect costs)
Summary: Supports high-risk, high-reward exploratory cancer research to generate preliminary data for future funding and innovation.
Key Information: This mechanism is paused and being restructured; next cycles are anticipated but not guaranteed.